Shopping Cart

Your shopping cart is currently empty

L-Clausenamide

Name: L-Clausenamide
Brand: TargetMol
SKU: T32614
Price: 397 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T32614Cas No. 201529-58-0

Alias (-)-Clausenamide

L-Clausenamide is an alkaloid extracted from the leaves of the yellow bark (Clausena lansium (Lour) skeels) and can be used to improve cognitive function. L-Clausenamide inhibits beta-amyloid (Aβ) toxicity and prevents the formation of neurofibrillary tangles by inhibiting tau phosphorylation. L-Clausenamide has neuroprotective activity and can be used to modulate stimuli triggered by Aβ25-35. L-Clausenamide can be used to study neurological disorders like Alzheimer's disease.

L-Clausenamide

😃Good

Purity: 99.99%

Catalog No. T32614Alias (-)-ClausenamideCas No. 201529-58-0

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$397	-	In Stock
5 mg	$970	-	In Stock
10 mg	$1,180	-	In Stock
25 mg	$1,580	-	In Stock
50 mg	$1,980	-	In Stock
100 mg	$2,500	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

Questions

Batch Information

Select Batch

Purity:99.99%

ee:98.85%

Appearance:Solid

Color:White

Resource Download

COA LCMS CSFC HNMR ORP

Product Introduction

Bioactivity

Description	L-Clausenamide is an alkaloid extracted from the leaves of the yellow bark (Clausena lansium (Lour) skeels) and can be used to improve cognitive function. L-Clausenamide inhibits beta-amyloid (Aβ) toxicity and prevents the formation of neurofibrillary tangles by inhibiting tau phosphorylation. L-Clausenamide has neuroprotective activity and can be used to modulate stimuli triggered by Aβ25-35. L-Clausenamide can be used to study neurological disorders like Alzheimer's disease.
In vitro	Reversing the overload in [Ca2+]i level stimulated by Aβ25-35 and reducing Aβ-mediated cell apoptosis in PC12 cells, L-Clausenamide (10 and 100 μM) demonstrates its protective effects[3]. In Aβ25-35-treated PC12 cells, L-Clausenamide (10 and 100 μM) inhibits the phosphorylation of p38 MAPK and down-regulates the expression of P53 and cleaved Caspase-3, as well as the ratio of Bax/Bcl-2[3].
Synonyms	(-)-Clausenamide

Chemical Properties

Molecular Weight	297.35
Formula	C₁₈H₁₉NO₃
Cas No.	201529-58-0
Smiles	[C@@H](O)([C@]1([C@H]([C@H](O)C(=O)N1C)C2=CC=CC=C2)[H])C3=CC=CC=C3
Relative Density.	1.270 g/cm3 (Predicted)

Storage & Solubility Information

Storage

In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 50 mg/mL (168.15 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.3630 mL	16.8152 mL	33.6304 mL	168.1520 mL
5 mM	0.6726 mL	3.3630 mL	6.7261 mL	33.6304 mL
10 mM	0.3363 mL	1.6815 mL	3.3630 mL	16.8152 mL
20 mM	0.1682 mL	0.8408 mL	1.6815 mL	8.4076 mL
50 mM	0.0673 mL	0.3363 mL	0.6726 mL	3.3630 mL
100 mM	0.0336 mL	0.1682 mL	0.3363 mL	1.6815 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc